Single dose of psilocybin for depression shows promising results in UK's first publicly funded randomized trial
medicalxpress - The first randomized controlled trial in the U.K. has found that a single dose of psilocybin, the active compound found in "magic mushrooms," produced significant improvements in depression compared with a placebo. This is the first publicly funded random…
AI Summary: A publicly funded randomized trial in the UK found that a single dose of psilocybin, delivered in a clinical setting, produced promising improvements for people with treatment-resistant major depressive disorder. The results suggest psychedelic-assisted therapy could be a viable addition to standard care—pending larger trials and careful safety monitoring—challenging old assumptions about one-and-done fixes.
FDA approves first drug for full range of narcolepsy symptoms
medicalxpress - The U.S. Food and Drug Administration has approved Orzeyful (oveporexton) tablets to treat narcolepsy type 1 in adults. Orzeyful marks the first medication approved for the full range of symptoms associated with narcolepsy type 1 and is the first approved…
AI Summary: The FDA has approved a medication that treats the full range of narcolepsy symptoms, including excessive daytime sleepiness and cataplexy, marking the first such comprehensive option for patients with narcolepsy type 1. Clinicians now have a single, regulated choice to address multiple debilitating symptoms rather than juggling piecemeal therapies.
NCCS Develops AI Tool to Predict Liver Cancer Recurrence After Surgery
oncodaily - National Cancer Centre Singapore (NCCS) shared on LinkedIn: “Can we now predict who’s at greatest risk for liver cancer recurrence? Congratulations to NCCS’ Professor Pierce Chow, Associate Professor Wai Leong Tam, Mr. Karthik Sekar, […]
AI Summary: A newly developed AI model predicts risk of liver cancer recurrence following surgical resection, integrating imaging and clinical variables to stratify patients more accurately. Early validation suggests the tool could personalize surveillance intensity and adjuvant therapy decisions, reducing unnecessary exams for low‑risk patients while focusing resources where recurrence risk is highest.
Some COVID-19 Patients Suffered Heart Damage, an Overlooked Coronavirus Protein May Explain Why
discovermagazine - Discover how the inconspicuous nucleocapsid protein from coronaviruses can trigger hyperinflammation, an effect not typically seen in other viruses.
AI Summary: Scientists identified a previously underappreciated SARS‑CoV‑2 protein that appears to damage heart tissue and may help explain persistent post‑COVID symptoms. The study ties the viral molecule to mechanisms of cardiac injury, opening diagnostic and therapeutic research paths for long COVID cardiac effects — proof that sometimes the troublemaker was hiding in plain sight.
Tufts Medicine CEO, CFO step down amid financial struggles
Jill Hughes / healthcaredive - Chief Executive Mike Dandorph will remain in the position through the end of September, after which he will be replaced by COO Phil Okala. Tufts is also swapping out its chief financial officer.
AI Summary: Tufts Medicine announced the departure of its CEO and CFO amid ongoing financial struggles, prompting a leadership shake‑up as the health system pursues fiscal stabilization. Trustees and executives are now tasked with steadying operations and advancing a turnaround plan while maintaining patient services — the corporate surgery no one asked for.
New bipartisan 340B reform bill curbs HHS' rebate pilot
fiercehealthcare - The SUSTAIN 340B Act introduced Wednesday would bring hospital-backed changes, like a clearinghouse to handle improper discounts, and codifies longstanding grey areas in the contentious subsidy program.
AI Summary: Bipartisan lawmakers introduced legislation to rein in HHS’s controversial 340B rebate pilot, pushing back on administrative changes that providers say threaten safety‑net funding. The bill aims to pause or limit the pilot while stakeholders debate drug‑pricing impacts, reimbursements and patient access — the predictable Washington policy scrum.
FDA approves Moderna’s mRNA flu vaccine
Ella Jeffries / beckershospitalreview - The FDA has approved Moderna’s mFLUSIVA (mRNA-1010), the first mRNA-based influenza vaccine in the U.S., for the prevention of seasonal influenza in adults ages 50 and older. The decision follows a monthslong regulatory process that included the agency’s …
AI Summary: The FDA has approved Moderna's mRNA flu vaccine, giving the familiar seasonal bug a high-tech reboot. Regulators cleared Moderna’s mRNA formulation for public use, signaling a shift toward next-generation influenza vaccines; rollout details, target groups and supply plans will follow as public health authorities coordinate distribution for the coming flu season.
- FDA's reversal and approval of Moderna mRNA flu shot (3)
- Public health guidance and flu season preparedness (3)
- What mFLUSIVA approval means for policy, coverage and mRNA (3)
FDA's reversal and approval of Moderna mRNA flu shot
Public health guidance and flu season preparedness
What mFLUSIVA approval means for policy, coverage and mRNA
HHS announces decertification of Kentucky-based organ procurement organization Network for Hope
fiercehealthcare - HHS Secretary Robert F. Kennedy Jr. said the decertification comes after federal reviews found “persistent patient safety failures.”
AI Summary: Federal health officials moved to decertify Network for Hope, a Kentucky-based organ procurement organization, after finding systemic safety and performance failures. The decision severs federal ties, triggers oversight and potential restructuring, and raises immediate questions about organ recovery operations and transplant continuity in the affected region. Bureaucracy meets blunt enforcement — inconvenient but necessary.
Swallowing faecal capsules reduces peanut allergy in six adults
Alice Klein / newscientist - Altering the gut microbiomes of people with peanut allergy using faeces donated from an allergy-free individual improved their peanut tolerance in a clinical trial
AI Summary: A small human trial showed swallowing fecal microbiota capsules reduced peanut allergy responses in six adults, while parallel animal and mechanistic work implicates bile-acid metabolites in restoring oral tolerance. The findings revive interest in microbiome-based desensitization, though larger trials are required before anyone starts prescribing ‘poop pills’ as routine therapy.
Sentara moves to end Anthem contracts in Virginia
Sy Mukherjee / healthcaredive - Nearly 380,000 patients could go out of network with the health system if the commercial, Medicare and Medicaid contracts lapse.
AI Summary: Sentara has escalated a contract standoff with Anthem Blue Cross Blue Shield, moving to terminate payer agreements after reimbursement talks collapsed. The health system says Anthem’s offers fall far short of needed rate increases, warning of disruptive network changes for Virginia patients while negotiations remain deadlocked.
HCA Healthcare acquires 40 Texas urgent care centers
fiercehealthcare - The deal sees the facilities rebranded as CareNow sites, and many are being tied to the existing footprint of two affiliate systems.
AI Summary: Healthcare giant HCA has purchased 40 urgent care centers across Texas, folding dozens of local clinics into its national network. The move rapidly expands outpatient capacity and promises standardized operations and scale efficiencies — while predictably sparking questions about consolidation’s effects on pricing, local autonomy and patient experience.
There are new blood tests for Alzheimer's. Should I have one?
medicalxpress - Australians have seen a flurry of headlines announcing the arrival of blood tests for Alzheimer's disease.
AI Summary: New blood tests detecting Alzheimer’s biomarkers are reaching clinical availability, promising earlier and less invasive diagnosis. Clinicians and consumers now face decisions about who should be tested, how to interpret results, and what interventions — if any — follow a positive biomarker. The tests shift diagnostic practice while raising ethical and counseling challenges.
NICE referral criteria miss up to 95% of women under 50 who go on to develop breast cancer within 10 years
medicalxpress - The National Institute for Health and Care Excellence (NICE) criteria used to decide who should be referred by GPs for further breast cancer risk assessment and specialist care miss up to 95% of women under 50 who will go on to develop the disease in the …
AI Summary: A recent analysis finds current NICE referral and screening criteria fail to flag the vast majority of women under 50 who later develop breast cancer, prompting criticism of one‑size‑fits‑all approaches. Researchers propose a new risk‑stratified method that could identify many more younger at‑risk women, pushing for policy updates to catch cancers earlier.
William Dale: Meeting Ethiopian National Leaders in Oncology and Palliative Care in Addis Ababa
oncodaily - William Dale, Professor and Vice Chair for Academic Affairs and Director, Center for Cancer and Aging at City of Hope, shared on LinkedIn: ”I have had the most remarkable week […]
AI Summary: William Dale traveled to Ethiopia to meet national health leaders and frontline clinicians, spotlighting geriatric oncology, palliative care and patient-centered cancer services. The visit included hospital engagements, training sessions and advocacy for system-wide improvements to strengthen cancer care access and workforce capacity across Ethiopian institutions.
AnMed’s cybersecurity outage drags into 5th day, closures unchanged
Giles Bruce / beckershospitalreview - Anderson, S.C.-based AnMed’s cybersecurity incident has stretched into a fifth day, with the same 13 service and practice locations closed as of Wednesday that were shuttered the day before. Closed locations include imaging sites in Anderson, Cannon, Clem…
AI Summary: AnMed’s IT outage stretched into its fifth day, forcing clinic disruptions and emergency contingency operations; later updates show some physician offices reopening while patients were alerted to suspicious messages tied to the incident. The episode underscores how a single cyber event can make a hospital’s day-to-day look, well, medieval.
- AnMed facility closures and patient access restoration (4)
- Patient alerts, data-theft claims and rising ransomware threats (4)
AnMed facility closures and patient access restoration
Patient alerts, data-theft claims and rising ransomware threats
Bluesky Mentions: @gizmodo.com
American Red Cross declares second-ever national blood supply crisis, urges ‘immediate’ donations
fiercehealthcare - Donations this summer are not “keeping pace with hospital demand,” with the non-profit citing extreme heat, poor air quality and foodborne illnesses as factors in the low donor turnout.
AI Summary: The American Red Cross has declared a rare national blood supply crisis and issued an urgent plea for donors as reserves plunged during summer shortages. Officials warned hospitals may face delays for transfusions and called for immediate donations across all blood types to avert disruptions to routine and emergency care.
Most breastfeeding mothers take medication, but many are making decisions without good information
medicalxpress - When a woman who is breastfeeding develops an infection or a flare of a chronic condition, she faces a decision that sounds simple but rarely is: Should she take the medication to treat her condition?
AI Summary: Surveys and reports show a majority of breastfeeding mothers use medications but often make decisions without adequate, evidence-based clinical guidance. The findings underline gaps in provider counseling and accessible information, urging health systems to improve communication so lactating patients can safely balance treatment needs with breastfeeding goals without needless anxiety.
Cigna bumps outlook as Q2 profit reaches $1.7B
Elizabeth Casolo / beckershospitalreview - The Cigna Group reported a profit of $1.7 billion for the second quarter of 2026, a year-over-year increase of more than 8%, according to a July 30 earnings report. Total revenue reached $71.7 billion for the quarter, up about 7% from the same period in 2…
AI Summary: Cigna posted stronger-than-expected second-quarter results, including a reported $1.7 billion profit, prompting the insurer to lift its financial outlook for the year. The company credited robust performance across core lines, citing continued growth in commercial and Medicare Advantage segments while signaling confidence in sustaining margin momentum.
FDA approves Simtriyo for treating ADHD in children and adults
medicalxpress - The U.S. Food and Drug Administration has approved Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults and children 6 years and older weighing ≥20 kg.
AI Summary: The FDA granted approval for Simtriyo to treat attention‑deficit/hyperactivity disorder in children and adults, adding a new prescription option to the ADHD toolkit. Regulators highlighted efficacy and safety data supporting the decision; clinicians and patients will now weigh the drug’s profile against existing therapies as rollout and coverage decisions play out.
Judge rejects states’ bid to pause Medicaid work requirements
Emily Olsen / healthcaredive - A federal judge this week said he wasn’t convinced that regulation detailing work requirements would cause irreparable harm to states. Still, the court will continue to hear the case.
AI Summary: A federal judge rejected a multi‑state request to pause implementation of Medicaid work requirement policies, finding insufficient grounds for an emergency stay. The ruling allows CMS guidance to remain in effect while legal challenges continue, leaving states and beneficiaries to navigate near‑term program changes amid ongoing litigation.
- AI and administrative responses to enrollment churn (3)
- Court rulings and Democratic opposition to the rule (3)
- Homeless people excluded from Medicaid exemptions (3)
- State rollouts, insurer readiness and early coverage losses (3)